2m 2m 2m 2m 2m 2m 2m
TENAYA THERAP (TNYA)
NASDAQ
$0.78-$0.007 (-0.89%)
Price as of Jun 03, 2026 7:55 PM EDT- $188.6MMarket Cap
- 61.22%1-Year Change
- BiotechnologyIndustry
TENAYA THERAP (TNYA)
$0.78-$0.007 (-0.89%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cost of Revenue | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Gross Profit | 0 N/A | 0 N/A | 0 N/A | 0 N/A | |
Sales and Marketing Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Research and Development Expense | -68.6M -20.91% | -86.7M -11.52% | -98.0M +3.70% | -94.5M +73.80% | |
Depreciation and Amortization Expense | 8.4M -0.38% | 8.5M -2.52% | 8.7M +34.33% | 6.5M +118.41% | |
Total Operating Expenses | 93.3M -19.51% | 115.9M -11.62% | 131.2M +4.44% | 125.6M +72.54% | |
Operating Profit | -93.3M -19.51% | -115.9M -11.62% | -131.2M +4.44% | -125.6M +72.54% | |
Interest Income | 2.7M -43.38% | 4.7M -32.87% | 7.1M +261.11% | 2.0M +1,709.26% | |
Interest Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Income and Expense and Net | 2.7M -43.38% | 4.7M -32.87% | 7.1M +261.11% | 2.0M +1,709.26% | |
Total Nonoperating Income and Expense | 2.7M -43.27% | 4.8M -32.21% | 7.1M +263.45% | 2.0M +2,201.18% | |
Income before Taxes | -90.6M -18.48% | -111.1M -10.44% | -124.1M +0.34% | -123.7M +70.05% | |
Income Taxes | 0 N/A | 0 N/A | 0 N/A | 0 N/A | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -90.6M -18.48% | -111.1M -10.44% | -124.1M +0.34% | -123.7M +70.05% | |
Net Income from Continuing Operations Applicable to Common | -90.6M -18.48% | -111.1M -10.44% | -124.1M +0.34% | -123.7M +70.05% | |
Basic EPS and Net Income | -0.59 -54.96% | -1.31 -22.02% | -1.68 -39.13% | -2.76 -32.68% | |
Diluted EPS and Net Income | -0.59 -54.96% | -1.31 -22.02% | -1.68 -39.13% | -2.76 -32.68% | |
Basic Weighted Average Shares | 153.0M +80.34% | 84.8M +14.96% | 73.8M +64.61% | 44.8M +152.75% | |
Diluted Weighted Average Shares | 153.0M +80.34% | 84.8M +14.96% | 73.8M +64.61% | 44.8M +152.75% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 100.5M +2,225.86% | 4.3M -90.54% | 45.7M -52.05% | 95.3M +149.87% | |
Short-Term Investments | 57.1M 0.00% | 57.1M -3.12% | 59.0M -35.39% | 91.3M -57.19% | |
Cash and Cash Equivalents and Short-Term Investments | 157.7M +156.60% | 61.4M -41.28% | 104.6M -43.90% | 186.5M -25.78% | |
Total Current Assets | 105.6M +56.71% | 67.4M -39.62% | 111.6M -42.41% | 193.8M -24.12% | |
Accumulated Depreciation | 39.9M +23.67% | 32.3M +32.66% | 24.3M +55.27% | 15.7M +66.32% | |
Property and Plant and Equipment and Net | 27.7M -22.83% | 35.9M -17.14% | 43.3M -15.20% | 51.0M +18.62% | |
Total Long-Term Assets | 4.2M -11.85% | 4.8M -15.15% | 5.7M +18.44% | 4.8M +33.92% | |
Total Assets | 146.9M +22.50% | 119.9M -29.66% | 170.5M -38.87% | 278.9M -11.22% | |
Income Taxes Payable | 277,000 -20.40% | 348,000 N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Current Liabilities | 15.4M -3.37% | 16.0M -29.73% | 22.7M -6.25% | 24.2M +11.36% | |
Total Long-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Long-Term Liabilities | 410,000 +45.91% | 281,000 +11.07% | 253,000 +10.96% | 228,000 +25.27% | |
Total Liabilities | 23.7M -12.66% | 27.1M -12.88% | 31.1M -12.59% | 35.6M -0.26% | |
Retained Earnings | -605.0M +17.61% | -514.4M +27.56% | -403.3M +44.44% | -279.2M +79.51% | |
Total Stockholders Equity | 123.3M +32.75% | 92.9M -33.40% | 139.4M -42.71% | 243.4M -12.62% | |
Total Shares Outstanding | 216.8M +150.47% | 86.5M +26.65% | 68.3M +2.20% | 66.9M +61.92% | |
Cash Flow | |||||
Cash from Operating Activities | -68.3M -24.57% | -90.5M -11.34% | -102.1M -2.25% | -104.4M +71.72% | |
Capital Expenditures | 618,000 -39.71% | 1.0M -17.27% | 1.2M -93.99% | 20.6M -17.88% | |
Cash from Investing Activities | 56.1M +4,858.71% | 1.1M -97.68% | 48.7M -41.76% | 83.7M +135.06% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 108.4M +127.03% | 47.7M +1,079.28% | 4.0M -94.79% | 77.8M -62.79% | |
Financials Ratio | |||||
Gross Margin | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Operating Margin | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Return on Assets | -67.90% -11.27% | -76.52% +38.59% | -55.21% +32.41% | -41.70% N/A | |
Return on Equity | -83.84% -12.38% | -95.69% +47.60% | -64.83% +36.80% | -47.39% N/A | |
Revenue Growth | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Current Ratio | 6.84 +62.19% | 4.22 -14.08% | 4.91 -38.57% | 7.99 N/A | |
Cash Ratio | 6.51 +2,307.17% | 0.27 -86.53% | 2.01 -48.86% | 3.93 N/A | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow